GALWAY, IRELAND--February 10, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German drugmaker Merck KGaA is planning to spend 250 million euro ($275 million) to build a new facility for biotech development and manufacturing for clinical studies at its Corsier-sur-Vevey site in Switzerland. Within this article: Details investment in Swiss plant, planned usage, additional Swiss and German investments
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
